You are here

News and press releases

XXI National Congress of the Spanish Society of Radiation Oncology (SEOR)


More than 700 national and international experts meet to present the latest advances in cancer treatment, where Spain aspires to be one of the world leaders in innovation and technology

Palma Congress Center welcomes more than 700 experts at the national congress of the Spanish Society of Radiation Oncology (SEOR), which meets in Palma for three days for the first time after the pandemic.

Mallorca thus becomes a meeting point for the exchange of knowledge on the latest innovations and treatments for cancer patients, such as the project for the implementation of proton therapy in Spain, an advanced proton radiotherapy technique that opens new treatment opportunities in patients with difficult or unique tumors, such as childhood cancer.

The XXI National Congress of SEOR is being held "at very interesting times, I would say exciting, for Spanish radiotherapy oncology", highlights the president of the Society, Dr. Antonio Gómez Caamaño. “The huge investments in renovation and expansion through the private initiative (Fundación Amancio Ortega) and the government of Spain (INVEAT plan) are going to make our country one of the world leaders both in innovation in cancer treatment and in advanced health-related technology.

Currently, the country is in the process of evaluating, acquiring and incorporating new external radiotherapy and brachytherapy equipment, which will facilitate access to modern techniques and improve care for cancer patients in Spain. This process, together with the implantation of proton therapy, will allow Spain to be one of the world leaders in this field.

Under the motto "Always with the Patient: Quality, Efficacy and Safety", the congress will feature a top-level scientific program, with the participation of renowned national and international speakers, such as Dr. Felipe Calvo Manuel, who will offer a keynote lecture on a disruptive biological concept: the possibility of performing dosimetry on circulating lymphocytes and the implications this may have on cancer treatments; or Dr. Vincenzo Valentini, who will analyze the future of the specialty.

Latest news

©2018 Melia. All rights reserved.